Lipitor Hearing Punted As Ranbaxy Counsel 'Trapped' In Israel
A New Jersey federal judge on Tuesday agreed to postpone class certification hearings in antitrust multidistrict litigation over cholesterol medication Lipitor after Ranbaxy Laboratories Ltd. told the court an unidentified attorney is...To view the full article, register now.
Already a subscriber? Click here to view full article